Literature DB >> 17485438

Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.

M F G Verberg1, M J C Eijkemans, N S Macklon, E M E W Heijnen, B C J M Fauser, F J Broekmans.   

Abstract

BACKGROUND: Milder stimulation protocols are being developed to minimize adverse effects of ovarian stimulation in in vitro fertilization (IVF) programs. A drawback is the possibility of an increased rate of insufficient ovarian response. This study aimed to develop a prognostic model for the prediction of cycle cancellation due to insufficient response to mild stimulation.
METHODS: A total of 174 IVF patients aged<38 years and with a body mass index (BMI)<28 Kg/m2 were treated with mild ovarian stimulation using a fixed daily dose (150 IU) of recombinant follicle-stimulating hormone (rFSH) from cycle day 5 and GnRH antagonist from the late follicular phase. In women with mono- or bifollicular growth (17%), the cycle was cancelled and the treatment was adjusted in a second treatment cycle by starting rFSH on cycle day 2.
RESULTS: In a multivariable logistic regression analysis, duration of infertility, menstrual cycle length, secondary infertility and BMI were included in the prediction model. The area under the receiver-operating characteristics curve of the model was 0.69. A probability cut-off for cancellation of 0.3 yielded an expected sensitivity of 33% and specificity of 92%. Analysis of ovarian response in the subsequent treatment cycle showed an improved ovarian response and a significant reduction in the cancellation rate.
CONCLUSIONS: With the presented model, it is possible to identify patients at risk for cycle cancellation, during mild ovarian stimulation, due to insufficient response. The contributing factors of the model suggest that ovarian aging and BMI are related to insufficient response to mild stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485438     DOI: 10.1093/humrep/dem089

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

2.  Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice.

Authors:  Olaf Gj Naether; Andreas Tandler-Schneider; Wilma Bilger
Journal:  Drug Healthc Patient Saf       Date:  2015-04-15

Review 3.  Should mild stimulation be the order of the day?

Authors:  Nalini Mahajan
Journal:  J Hum Reprod Sci       Date:  2013-10

4.  Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol.

Authors:  Frank J Broekmans; Pierre J M Verweij; Marinus J C Eijkemans; Bernadette M J L Mannaerts; Han Witjes
Journal:  Hum Reprod       Date:  2014-06-05       Impact factor: 6.918

Review 5.  Models Predicting Success of Infertility Treatment: A Systematic Review.

Authors:  Alireza Zarinara; Hojjat Zeraati; Koorosh Kamali; Kazem Mohammad; Parisa Shahnazari; Mohammad Mehdi Akhondi
Journal:  J Reprod Infertil       Date:  2016 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.